Cargando…

Current State of Cell Therapies for Breast Cancer

Metastatic breast cancer (BC) is an aggressive form of cancer and is an absolute challenge to treat. This review discusses the standard treatments available for metastatic BC. It further highlights the rationale for targeting oncodrivers, tumor-associated antigens, and neoantigens in BC. Explaining...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gautam, Namrata, Elleson, Kelly M., Ramamoorthi, Ganesan, Czerniecki, Brian J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336570/ https://www.ncbi.nlm.nih.gov/pubmed/35880940 http://dx.doi.org/10.1097/PPO.0000000000000607

Ejemplares similares

Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination
por: Zachariah, Nadia Nocera, et al.
Publicado: (2021)

Differentiation and Regulation of T(H) Cells: A Balancing Act for Cancer Immunotherapy
por: Basu, Amrita, et al.
Publicado: (2021)

Circulating Tumor Cells in Breast Cancer Patients: An Evolving Role in Patient Prognosis and Disease Progression
por: Graves, Holly, et al.
Publicado: (2011)

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
por: Law, Vincent, et al.
Publicado: (2021)

Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy
por: Terhune, Julia, et al.
Publicado: (2013)

Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinoma
por: Ramamoorthi, Ganesan, et al.
Publicado: (2022)

Clinical development of immunotherapies for HER2(+) breast cancer: a review of HER2-directed monoclonal antibodies and beyond
por: Costa, Ricardo L. B., et al.
Publicado: (2020)

Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response
por: Kodumudi, Krithika N., et al.
Publicado: (2019)

Oncoplastic Surgery: Keeping It Simple With 5 Essential Volume Displacement Techniques for Breast Conservation in a Patient With Moderate- to Large-Sized Breasts
por: Chatterjee, Abhishek, et al.
Publicado: (2017)

Tumor Characteristics Associated with Axillary Nodal Positivity in Triple Negative Breast Cancer
por: Chintapally, Neha, et al.
Publicado: (2023)

Factors Influencing Lymph Node Positivity in HER2/neu+ Breast Cancer Patients
por: Englander, Katherine, et al.
Publicado: (2023)

Novel evolutionary dynamics of small populations in breast cancer adjuvant and neoadjuvant therapy
por: Artzy-Randrup, Yael, et al.
Publicado: (2021)

Th1 cytokines in conjunction with pharmacological Akt inhibition potentiate apoptosis of breast cancer cells in vitro and suppress tumor growth in vivo
por: Showalter, Loral, et al.
Publicado: (2020)

Sunitinib Combined with Th1 Cytokines Potentiates Apoptosis in Human Breast Cancer Cells and Suppresses Tumor Growth in a Murine Model of HER-2(pos) Breast Cancer
por: Ghimirey, Nirmala, et al.
Publicado: (2021)

Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway
por: Jia, Yongsheng, et al.
Publicado: (2021)

Current State of Breast Cancer Diagnosis, Treatment, and Theranostics
por: Bhushan, Arya, et al.
Publicado: (2021)

Genitourinary melanoma: An overview for the clinician
por: DePalo, Danielle K., et al.
Publicado: (2022)

Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib
por: Showalter, Loral E., et al.
Publicado: (2019)

T-helper 1-type cytokines induce apoptosis and loss of HER-family oncodriver expression in murine and human breast cancer cells
por: Namjoshi, Prachi, et al.
Publicado: (2019)

Current state of surgical management for male breast cancer
por: Popa-Nimigean, Vladimir, et al.
Publicado: (2019)

A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2(+) breast cancer
por: Costa, Ricardo, et al.
Publicado: (2019)

Breast cancer stem cells: implications for therapy of breast cancer
por: Morrison, Brian J, et al.
Publicado: (2008)

Nanomedicine applications in the treatment of breast cancer: current state of the art
por: Wu, Di, et al.
Publicado: (2017)

Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and Prevention
por: Nocera, Nadia F., et al.
Publicado: (2016)

Current application of phytocompound-based nanocosmeceuticals for beauty and skin therapy
por: Ganesan, Palanivel, et al.
Publicado: (2016)

Current status of gene therapy for breast cancer: progress and challenges
por: McCrudden, Cian M, et al.
Publicado: (2014)

Murine Dendritic Cells Grown in Serum-Free Culture Show Potent Therapeutic Activity when Loaded with Novel Th Epitopes in an Orthotopic Model of HER2(pos) Breast Cancer
por: Showalter, Loral E., et al.
Publicado: (2021)

Intraoperative radiation therapy for breast cancer patients: current perspectives
por: Dutta, Sunil W, et al.
Publicado: (2017)

Targeting Engineered Nanoparticles for Breast Cancer Therapy
por: Ganesan, Kumar, et al.
Publicado: (2021)

Personalizing Radiation Treatment Delivery in the Management of Breast Cancer
por: Ahmed, Kamran A., et al.
Publicado: (2018)

Current state of therapy for pain and inflammation
por: Abramson, Steven B, et al.
Publicado: (2005)

Current State of Compassionate Phage Therapy
por: McCallin, Shawna, et al.
Publicado: (2019)

Antithrombin Therapy: Current State and Future Outlook
por: Rodgers, George M., et al.
Publicado: (2023)

Current State of CAR T-Cell Therapy in Chronic Lymphocytic Leukemia
por: Mancikova, Veronika, et al.
Publicado: (2021)

Current Molecular Combination Therapies Used for the Treatment of Breast Cancer
por: Wang, Yiling, et al.
Publicado: (2022)

Current treatment of early breast cancer: adjuvant and neoadjuvant therapy
por: Miller, Elizabeth, et al.
Publicado: (2014)

Intensity modulated radiation therapy for breast cancer: current perspectives
por: Buwenge, Milly, et al.
Publicado: (2017)

Current Photoactive Molecules for Targeted Therapy of Triple-Negative Breast Cancer
por: Dias, Cristina J., et al.
Publicado: (2021)

Interference-Free HER2 ECD as a Serum Biomarker in Breast Cancer
por: Lam, Lian, et al.
Publicado: (2014)

Moving beyond PARP Inhibition: Current State and Future Perspectives in Breast Cancer
por: Palleschi, Michela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lf3jak0mu371o16dstfcliqje8